Early Look

Friday, July 24, 2026

Futures

Up/Down

%

Last

Dow

272.00

0.52%

52,166

S&P 500

15.25

0.21%

7,460

Nasdaq

24.50

0.09%

28,645

 

 

After posting hefty losses on Thursday on fears of rising inflation amid surging oil prices/Treasury yields, and underwhelming tech earnings from GOOGL, TSLA, and others , U.S. averages are pointing to a higher open after INTC reported a beat and raise quarter giving some life back into the tech trade. On Thursday, the S&P 500 and the Dow slid 1.2% and 1.0%, respectively, while the tech-heavy Nasdaq tanked 2.2%. All three indexes suffered their largest single-day percentage drops in a month, with all three on track for weekly losses. Consumer discretionary (XLY) and communication services (XLC) were among the day's biggest laggards, both falling more than 5%. Front-month WTI and Brent crude futures settled up 6.2% and 7.0%, respectively, after U.S. President Trump vowed to punish Iran for Houthi attacks on two Saudi oil tankers in the Red Sea, evidence that the U.S.-Israeli war on Iran is escalating and spreading. This morning, WTI crude oil prices pull back -2.75% to $89.65 but still on track for big weekly gains. In trade news, Trade Act of 1974 invoked reissued new duties on trading partners as the Trump administration imposed new levies on 60 trading Partners across the globe, collecting duties of between 10% and 12.5%. In Asian markets, The Nikkei Index declined 1,811 points to 64,611, the Shanghai Index dropped -62 points to 3,814, and the Hang Seng Index slipped -247 points to 24,963, ending the week lower. In Europe, the German DAX is up 210 points to 24,973, while the FTSE 100 rises 40 points to 10,678. The KOSPI closed down -5.7% Friday, with Samsung falling -7.6% and SK Hynix dropping -8.3%. This brings the KOSPI's decline to -28% from its June peak, with SK Hynix now down -40% and Samsung down -33% from their own peaks.

 

Market Closing Prices Yesterday

  • The S&P 500 Index stumbled -90.66 points, or 1.21%, to 7,408.30
  • The Dow Jones Industrial Average fell -506.93 points, or 0.97%, to 51,711.65
  • The Nasdaq Composite sunk -553.21 points, or 2.15%, to 25,137.69
  • The Russell 2000 Index declined -19.75 points, or 0.67% to 2,940.19

Economic Calendar for Today

  • 9:45 AM ET S&P Global Manufacturing PMI, June-flash…est. 54.3
  • 9:45 AM ET S&P Global Services PMI, June-flash…est. 51.5
  • 9:45 AM ET S&P Global Composite PMI, June-flash
  • 10:00 AM ET                 New Home Sales M/M for June…est. 610K
  • 1:00 PM ET                    Baker Hughes Weekly rig count data

Earnings Calendar:

  • Earnings Before the Open: AXP BAH CHTR CNI EAF FHB FLG GNTX HCA LBTYA LW NDLS NEE SLB SXT THX VZ

 

 

Macro

Up/Down

Last

Nymex

-2.54

89.65

Brent

-2.94

97.75

Gold

15.80

4,066.00

EUR/USD

0.0014

1.1391

JPY/USD

-0.14

163.72

10-Year Note

-0.01

4.68%

 

World News

  • The Trump administration imposed new levies on 60 trading Partners across the globe, collecting duties of between 10% and 12.5%. The tariffs span immediate neighbors like Canada and Mexico to more distant countries and blocs such as Japan and the European Union. A new provision, Section 122 of the Trade Act of 1974, was then used to address the "large and serious" U.S. balance-of-payments deficit..

Sector News Breakdown

Consumer

  • Boston Beer (SAM) Q2 EPS $4.96 vs. est. $4.83; Q2 revs $568.3M vs. est. $567.45M; Q2 depletions decreased 6% and shipments decreased 4.5%; reaffirms FY26 EPS view $8.50-$10.50 vs. est. $9.38 and reaffirms 2026 depletions and shipments view of down low-single digits to mid-single digits.
  • Boyd gaming (BYD) Q2 Adj. EPS $1.93 (est. $1.88); Rev $1.034B (est. $1.037B); Total Adj. EBITDA $350.5Mm (vs $357.9Mm PY) vs est $310.96Mm; MW&S $556.9Mm, LV Locals $225.9Mm, Online $158.2Mm, Dt LV $52.1Mm; Div $0.20; buyback $156Mm, $551Mm auth.; debt $2.6B.
  • Comfort Systems (FIX) Q2 EPS $12.53 (est. $10.45); Rev $3.27B (est. $2.99B); EBIT $558.0Mm (est. $478.6Mm); GP $844.2Mm (~25.9% margin); Operating Cf $1.14B; Backlog $14.06B (+73% YoY, +13% QoQ); Div $0.90 (+$0.10)
  • Decker’s Outdoors (DECK) Q1 EPS $0.94 vs est $0.87 on revs $1.019B vs est $1.018B, gr mgn 56.4%; guides FY revs $5.86-5.91B vs est $5.899B, EPS $7.35-7.50 vs est $7.48 and gr mgn 56.5%

Energy, Industrials and Materials

  • C.H. Robinson (CHRW) said a Texas jury issues advisory verdict vs company, two other defendants in suit related to trucking accident; verdict awarded $604M compensatory damages, which could be assessed against company; disagrees with advisory verdict, expects to appeal if verdict made final.
  • Newmont Mining (NEM) Q2 adj EPS $2.10 vs. est. $2.18; Q2 sales $6.11B vs. est. $6.49B; Q2 net income drops -33% to $2.2B q/q and adj Ebitda -27% to $3.76B; said expects to spend $1.95B in 2026 in sustaining cap through targeted investments in critical infrastructure, including tailings Solutions; FY guide remains unchanged; Q2 average realized gold price was $4,414 per ounce and produced 1.3 mln attributable gold ounces.
  • World Kinect (WKC) Q2 Adj. EPS $1.29 vs. est. $0.75 (beat); Rev $13.591B vs. est. $10.505B (beat, 2 est.); Adj. EBITDA $136Mm vs est $96.83Mm; Aviation Gp $208Mm (record high), Marine Gp $80Mm (record high), Land Gp $77Mm; raises FY26 Adj. EPS guide to $3.20–$3.40; qtrly div. +15% to $0.23/shr; repurchased $14Mm of stock Q2.

Financials

  • Enova International (ENVA) Q2 adj EPS $4.31 vs est $3.96, adj EBITDA $256Mm vs est $237.6Mm on revs $928.9Mm vs est $909.62Mm
  • Hartford Financial (HIG) Q2 adj EPS $3.42 vs. est. $3.16; Q2 revs $7.26B vs. est. $7.19B; Net income for Q2 rose 31% y/y, driven by higher premiums and investment income; Q2 book value per diluted share $70.28; Q2 net income $945M; said 5% written premium growth in Business Insurance contributed to higher earned premiums.
  • Kinsale Capital (KNSL) Q2 adj EPS $5.54 vs est $5.10 on gr premiums written $527.6Mm vs est $551.73Mm, annualized ROE 28.9%, combined ratio 75.5%.
  • Rexford Industrial (REXR) Q2 Core FFO/share $0.63 (est. ~$0.61); Core FFO $141.4Mm; Rev $245.5Mm (est. $240.2Mm); Portfolio NOI $186.8Mm; SS Cash NOI +1.5%; Occ. 95.7%; Comp. Rent -2.8% NE / -11.3% cash; GAAP loss ($2.26)/share (non-cash impairment); FY26 Core FFO $2.38–$2.43 (raised); FY26 GAAP loss ($1.32)–($1.27); Disp. guide $1.5–$2.0B; Net Debt 4.5x; Div $0.435; $100Mm buyback in Q2, new $1.0B auth.
  • Robert Half (RHI) Q2 EPS $0.26 (est. $0.26, inline); Rev $1.336B (est. $1.322B); Net Inc $26.3Mm; Pretax $40.6Mm; within prior Q2 guide ($1.275–$1.375B / $0.20–$0.30 EPS).
  • Selective Insurance (SIGI) Q2 adj EPS $1.95 vs est $1.66 on net premiums written $1.22B vs est $1.214B, adj ROE 13.7%, adj Bv/shr $60.56.
  • SLM Inc. (SLM) Q2 EPS $0.29 vs. est. $0.48; Q2 net interest income of $333M, 2Q net interest margin of 4.75%, 2Q net income of $59M and 2Q ROCE of 9.9%; Private Education Loan originations increased 4.5% from the year-ago quarter; average loans outstanding, net, totaled $21.1B during the quarter; backs year EPS outlook.
  • Stripe is in talks to acquire OpenRouter, a startup that helps developers choose between artificial-intelligence models, according to people familiar with the matter. A transaction could be announced soon, though the talks could still fall apart. The exact price being discussed couldn't be learned, but some of the people said the business could fetch about $10 billion in a sale – WSJ reported.
  • Wise (WSE) shares fall after the U.S. Office of the Comptroller of the Currency denied Wise's application for a National Trust bank Charter as it was incompatible with Fed's new policies for payment system access. Wise plans to submit a new application under GENIUS Act framework, which pertains to digital assets like stablecoins

Healthcare

  • AtriCure (ATRC) Q2 adj EPS $0.18 vs est $0.00, adj EBITDA $27.3Mm vs est $19.94Mm on revs $153.6Mm vs est $151.8Mm, gr mgn 77.2%; guides FY revs $602-610Mm vs est $604.99Mm, adj EBITDA $85-89Mm vs est $80.53Mm and adj EPS $0.24-0.32 vs est $0.06.
  • Edwards Lifesciences (EW) Q2 EPS $0.78 vs. est. $0.74; Q2 revs $1.74B vs. est. $1.7B; Q2 TAVR sales rose 11.3% y/y to $1.3B; guides Q3 EPS $0.71-$0.77 vs. est. $0.75 and revs $1.63B-$1.71B vs. est. $1.69B; Narrows higher FY26 revenue growth view to 10%-11% from 9%-11%; affirms FY26 EPS view of $2.95-$3.05 vs. consensus $3.01.
  • Novo Nordisk (NVS) ‌said it is seeking a preliminary U.S. court injunction to immediately block obesity and diabetes drug advertisements by Eli Lilly (LLY).
  • Summit Therapeutics (SMMT) reiterated concerns about remaining a going concern in its June quarter SEC filing. The company used the same language in its March quarter earnings filing.
  • Tenet Healthcare (THC) Q2 adj EPS $6.12 vs. est. $4.26 and Q2 revs $5.63B vs. est. $5.44B; now sees FY26 adjusted EPS $20.30-$21.69 above consensus $17.85 and year revs $21.9B-$22.5B, vs. consensus $21.98B; authorizes $2B increase to share repurchase program.

Technology, Media & Telecom

  • Intel Corp. (INTC) Q2 adj EPS $0.42 vs est $0.21 on revs $16.13B vs est $14.417B, adj gr mgn 41.8% vs est $38.76%; guides Q3 revs $15.8-16.8B vs est $15.103B, adj gr mgn 42.0% vs est $39.77% and adj EPS $0.38 vs est $0.27; raises CAPEX est from $18B to $20B.
  • AppFolio (APPF) Q2 EPS $1.71 vs. est. $1.69; Q2 revs $281.12M vs. est. $277.2M; sees FY26 non-GAAP operating margin range as a percentage of rev is increasing to 26.5% - 28.0%; sees FY revs $1.11B-$1.12B vs. est. $1.12B.
  • Digital Realty (DLR) Q2 EPS $1.21 vs. est. $0.47; Q2 adj FFO $2.65 and Q2 total bookings $208M; sees FY core FFO $8.15-$8.20 up from prior $8.00-$8.10 and raises FY adj Ebitda outlook as well; said signed more than $100 million of 0-1 MW plus Interconnection bookings for the first time.
  • Knowles Inc. (KN) Q2 Adj. EPS $0.33 vs. est. $0.30, beat; revenue $166.8Mm vs. est. $163.28Mm, beat, up 14% YoY; bookings and backlog were highlighted as drivers; Q3 revenue guidance $167Mm-$177Mm vs est $169.93Mm.
  • MaxLinear (MXL) Q2 revs rose 55% y/y to $168.8M vs. est. $164.6M; Q2 Infrastructure business up 145% y/y reflecting accelerated adoption of optical AI data center products.
  • RingCentral (RNG) Q2 EPS $1.22 vs. est. $1.17 and revs $657M vs. est. $650.6M; sees Q3 revenue $664M-$670M, vs. consensus $663.6M; raises FY26 EPS $4.96-$5.10 from prior $4.76-$4.97 and est. $4.95; boosts FY26 revenue $2.635B-$2.646B vs. est. $2.63B; raises quarterly dividend from 7.5c per share to 12.5c per share; NICE expanded its partnership with RNG under a new multi-year agreement, adding resale of RingCentral’s UCaaS product RingEX.
  • SAP AG (SAP) Q2 adj EBIT $2.7B vs. est. $2.8B; Q2 revs rose 9% y/y to EU9.88B vs. est. EU9.85B; Q2 IFRS operating profit rises 8% to EU2.64B; Q2 current cloud backlog EU22.9B; backs FY26 cloud revenue EUR 25.8B-EUR26.2B.
  • SS&C Technologies (SSNC) Q2 EPS $1.76 vs. est. $1.68; Q2 revs $1.69B vs. est. $1.66B; sees Q3 adj EPS $1.73-$1.79, vs. est. $1.72 and sees Q3 revs $1.657B-$1.697B vs. est. $1.69B; sees FY revenue $6.672B-$6.832B vs. est. $6.75B
  • VeriSign (VRSN) Q2 EPS $.38 vs. est. $2.36; Q2 revs rose 6% y/y to $434.6M vs. est. $433.1M; authorized additional $884M for share repurchases, buyback authorization now $1.5B; posted 5.1% y/y increase in .com and .net domain name registrations drove revenue growth for Q2 and 12.7M new .com and .net registrations, up from 10.4M y/y.

Mid-Morning Look

Friday, July 24, 2026

Index

Up/Down

%

Last

DJ Industrials

146.30

0.28%

51,859

S&P 500

8.92

0.12%

7,416

Nasdaq

-112.04

0.45%

25,025

Russell 2000

-2.05

0.07%

2,938

 

 

U.S. stock markets are mixed early as tech weakness drags the Nasdaq lower, Smallcaps are lower, but the S&P 500 holding up well as strength in most sectors help offset the early tech weakness. Real Estate (+2.3%), Energy (+1.4%) and Communications (+0.86%) are outperformers among S&P sector ETFs, while Consumer Discretionary (+0.15%), Financials (+0.25%) and Technology (-1.32%) pace the underperformers with 10 sectors gaining versus 1 declining. U.S. stocks close the week on a subdued note following days dominated by geopolitical headwinds, an earnings deluge, a weak tape and rising inflation expectations. Technology continues to dominate market narratives, as investors contend with a growing wall of worry over AI spending, rising competition from Chinese frontier models, and increasingly crowded positioning and seeing semiconductors pulling back further after a massive multi-year run.

 

In geopolitical news, U.S. threats to Iran keep a bid under oil prices, supporting U.S. Treasury yields, while tech/cons discretionary stocks continued to wobble post earnings results (large capex spending) and the USTR confirmed sweeping tariffs on trading partners. President Trump told Axios on Thursday that he is seriously considering restarting major combat operations in Iran including strikes that would be bigger than the ones carried out during Operation Epic Fury.

 

In trade news, the Trump administration is set to impose new 10% and 12.5% tariffs on 60 trading partners, including the European Union, over what it says is insufficient enforcement of forced labor restrictions. The measures take effect as the temporary 10% global tariff expires and represent another step toward President Donald Trump's broader trade agenda after the U.S. Supreme Court earlier this year struck down portions of his reciprocal tariff framework.

Economic Data

  • S&P Global July flash composite PMI at 53.6 (vs 51.9 in June); S&P Global July flash services PMI at 53.6 (forecast 51.5); S&P Global July flash manufacturing PMI at 53.8 (forecast 54.3).
  • June single-family home sales 628K unit ann. Rate, (v. est. 610K) as June single-family home sales +1.6% vs.  May -4.3%; June home sales Northeast +3.6%, Midwest +2.5%, South +9.9%, West -22.4%; June new home supply 9.3 months' worth at current pace vs May 9.4 months.

 

 

Macro

Up/Down

Last

WTI Crude

-2.62

89.57

Brent

-3.43

97.26

Gold

9.80

4,060.00

EUR/USD

-0.0004

1.1372

JPY/USD

-0.06

163.79

10-Year Note

-0.036

4.666%

 

Sector Movers Today

  • Software sector rebound: SAP reported mixed 2Q26 results with worse-than-expected non-IFRS EPS of EU159 vs. consensus EU1.75 and operating profit of EU2.74B vs. consensus EU2.89B citing the sequential deceleration of cloud and total revenue growth, an unusually low stock-based compensation expense in Q1, accelerated investments into R&D as well as the dilutive impact of the Reltio acquisition but revs of EU9.88B topped est. EU9.85B and cloud revenue of EU6.28B beat consensus EU6.26B. RNG reported a beat & raise 2Q, with revenue of $657M, up 5.9% Y/Y, and operating margins of 23.4%, up 90bps Y/Y and number of customers using at least one paid AI product has doubled Y/Y. CRM said the U.S. Department Of Veterans Affairs awarded them a $1.6B, 3-yr Agentic Enterprise License deal. ORCL signs 10-year software contract with Pentagon worth up to $7B/will supply on-premises software to the U.S. DoD over 10 years in a contract worth up to $7B.
  • Telecom & Cable sector: VZ beat Q2 EPS ($1.30 vs. $1.27) and wireless service expectations, then raised its FY26 outlook as now sees adjusted EPS of $4.99-$5.04, up from a previous ceiling of $4.99; Q2 total operating revs $34.3B missed est. $35.16B, but Q2 postpaid phone net additions 184,000 topped estimates 103,900 with Q2 Broadband net additions 348,000. In cable, CHTR Q2 revs fell -1.7% y/y to $13.5B vs. est. $13.52B, as adj EBITDA declined 4.3% y/y -year to $5.4B as revenue fell and costs remained flat; Spectrum Internet customers declined by 172,000 in Q2, video customers decreased by 21,000 and fell by 107,000 y/y.
  • In Oil Services: SLB beat Q2 Wall Street expectations for profit with EPS of $0.55 topping the $0.51 estimate on better revs $8.97B, lifting other service names (BKR, HAL), though the company flagged that Middle East first-half revenue declined on lower activity and conflict-related operational disruptions, with the timing of a full recovery remaining uncertain. Overall, the whole energy complex remains well bid this week as oil prices slip Friday, but up big on the week on Iran.  BP is in advanced talks to sell its solar business, Lightsource, to a consortium backed by Kuwait's sovereign wealth fund, the Financial Times reported.

 

Stock GAINERS

  • AMKR +1%; after announced multi-year, $1.5B agreement with NVDA to expand advanced chip packaging and test capacity in the U.S.; partnership includes a prepayment from NVDA to support expansion of AMKR's U.S. advanced packaging operations, including capacity in Arizona.
  • BAH +14%; shares rallied on earnings results while forecasts FY adj. EPS to $6.00-$6.35 and revenue in the range of $11.2B-$11.70B vs analysts' est of EPS $6.29/$11.64B.
  • DLR +13%; shares jumped as Q2 revenue rises 29% y/y to $1.9B, lifts 2026 revenue outlook to $6.85B-$6.95B, and core FFO outlook on strong customer demand; posted record bookings and rental rate increases on renewal leases supported revenue and backlog growth.
  • EW +3%; delivered an upside surprise on Q2 sales and EPS of 2% and 4% and was upgraded at Leerink saying co checks nearly all the boxes: 1) a positive earnings setup, 2) an attractive catalyst path including the final TAVR NCD update, 3) multiple underappreciated tailwinds for TAVR.
  • RNG +20%; reported a beat & raise 2Q, with revenue of $657M, up 5.9% Y/Y, and operating margins of 23.4%, up 90bps Y/Y and number of customers using at least one paid AI product has doubled Y/Y
  • SAP +7%; 2Q operating income missed Street estimates (partially from M&A expenses), and there are signs of revenue and margin growth deceleration, but Current Cloud Backlog continues showing strong growth, and management reaffirmed the 2026 FCF and 2027 top-line growth.
  • SLB +8%; as the oil service giant beat Q2 Wall Street expectations for profit with EPS of $0.55 topping the $0.51 estimate on better revs $8.97B, lifting other service names.
  • THC +21%; shares jumped on results/guidance as Q2 adj EPS $6.12 vs. est. $4.26 and Q2 revs $5.63B vs. est. $5.44B; now sees FY26 adjusted EPS $20.30-$21.69 above consensus $17.85 and year revs $21.9B-$22.5B, vs. consensus $21.98B (better than comp CYH results the day prior).
  • VZ +3%; beat Q2 EPS ($1.30 vs. $1.27) and wireless service expectations, then raised its FY26 outlook; secured a deal worth more than $1 billion to provide dark fiber connectivity for GOOGL data centers

 

Stock LAGGARDS

  • AXP -5%; shares fall; Q2 revenue rose 10% y/y to $19.64B vs. est. $19.69B driven by higher card member spending while EPS of $4.53 topped the $4.41 estimate; raised full-year 2026 revenue growth guidance to 10% and maintains FY 2026 EPS guidance at $17.30 to $17.90.
  • CHTR -4%; Q2 revs fell -1.7% y/y to $13.5B vs. est. $13.52B, as adj EBITDA declined 4.3% y/y -year to $5.4B as revenue fell and costs remained flat; Spectrum Internet customers declined by 172,000 in Q2, video customers decreased by 21,000 and fell by 107,000 y/y.
  • DECK -3%; posted in-line Q2 sales of $1.02B and maintained its FY sales outlook of $5.86B-$5.91B while raising GY26 EPS view by a nickel vs. prior view to $7.35-$7.50 though noted Q2 gross margin is expected to be down due to tariffs and rising freight cost
  • HIG -3%; shares slipped after messy quarter as operating EPS of $3.42 topped ests $3.20 while underwriting was the primary source of weakness as the underlying loss ratio deteriorated 1.3pts y/y to 58.3%, with the pressure concentrated in Middle Market and National Accounts.
  • INTC -3%; reverses overnight strength; posted its strongest revenue growth in more than fifteen years, with 2Q revenue of $16.1B (up 25% y/y), roughly $1.8B above the guidance midpoint, adj-GM of 41.8% (280bps above guide), and adj-EPS of $0.42 versus $0.20 guidance and $0.22 consensus.
  • SMMT -8%; shares fell after announced up to $380M at the market equity sales program, with proceeds used to develop lead product candidate, ivonescimab, including clinical trials in non-small cell lung cancer (NSCLC), colorectal cancer, other solid tumors; also posted Q2 net loss that narrowed
  • WSE -6%; after the U.S. Office of the Comptroller of the Currency denied Wise's application for a National Trust bank Charter as it was incompatible with Fed's new policies for payment system access.
  • ZVRA -20%; shares slide after the European Medicines Agency's CHMP adopted a negative opinion on the co’s marketing application for arimoclomol, saying the treatment's efficacy had not been sufficiently demonstrated.

Closing Recap

Friday, July 24, 2026

Index

Up/Down

%

Last

DJ Industrials

234.86

0.45%

51,946

S&P 500

3.66

0.05%

7,411

Nasdaq

-161.87

0.64%

24,975

Russell 2000

-10.16

0.35%

2,930

 

 

 

 

 

 

 

 

 

U.S. stocks finished mixed as oil prices fell on news of a Pakistan-driven mediation between the US/Iran through help with China and indications that some tankers are making it through the two maritime chokepoints. After a bounce this morning on the peace headlines, technology stocks sputtered amid a late day sell-off, adding to weekly declines as the Semi index (SOX) fell -4.25%. Nearly all eleven S&P 500 sectors finished higher, led by REITs, Materials, Healthcare and Consumer Staples, but the tech heavy Technology weakness pushed major averages lower despite the positive market breadth. Treasury yields fell today but surged to 18-month highs this week and crude oil surged on the week amid increased U.S./Iran tensions, hitting highest levels in 7-weeks and renewing inflation concerns into next week’s FOMC policy meeting on Wednesday. Markets await a catalyst filled window in the coming week as Wednesday (META, MSFT) and Thursday (AAPL, AMZN) out with mega-cap tech earnings and FOMC driving market direction with its policy meeting, though no rate changes are anticipated. In trade news, the Trump administration is set to impose new 10% and 12.5% tariffs on 60 trading partners, including the European Union, over what it says is insufficient enforcement of forced labor restrictions. The measures take effect as the temporary 10% global tariff expires and represent another step toward President Trump's broader trade agenda after the U.S. Supreme Court earlier this year struck down portions of his reciprocal tariff framework. For the week, the S&P 500 fell 0.6%, the Dow fell 0.4% and the Nasdaq fell 2.1%.

Economic Data

  • S&P Global July flash composite PMI at 53.6 (vs 51.9 in June); S&P Global July flash services PMI at 53.6 (forecast 51.5); S&P Global July flash manufacturing PMI at 53.8 (forecast 54.3).
  • June single-family home sales 628K unit ann. Rate, (v. est. 610K) as June single-family home sales +1.6% vs.  May -4.3%; June home sales Northeast +3.6%, Midwest +2.5%, South +9.9%, West -22.4%; June new home supply 9.3 months' worth at current pace vs May 9.4 months.

Commodities

  • U.S. WTI crude oil futures settle at $89.31/bbl, down $2.88, or 3.12% while Brent crude slipped Brent -$3.91 or 3.88% to settle at $96.78 per barrel after surging 7% overnight to a two-month high of $102 after attacks by Iran-aligned Houthis on Saudi tankers in the Red Sea risk choked off a second crucial Middle East route for global oil supplies, alongside Iran's curb of the Strait of Hormuz. President Trump threatened "major military punishment" for Iran and its Houthi allies, while the U.S. military conducted a 13th consecutive night of attacks. But prices fell today on 3rd party mediation headlines. In metals markets, August gold rises $20.60, or +0.51%, to settle at $4,070.80 an ounce while September Silver rises $0.85, or +1.47%, to settle at $58.91 an ounce.

Currencies & Treasuries

  • The U.S. dollar posted its biggest weekly gain since mid-June (DXY +0.7%), buoyed by the rise in oil prices, while the yen posted its largest weekly percentage decline in more than two months (down at 40-yr lows vs the greenback). Japan's Finance Minister Satsuki Katayama once again reiterated on Friday the government's readiness to take action in the foreign exchange market. Against the Japanese yen, the dollar weakened 0.02% to 163.8 but was up nearly 0.9% on the week, which would mark its strongest week since May 15 (off 40-yr highs of 163.98 on Thursday).
  • Treasury yields down on day, but up big on week hitting 18-month highs on Thursday. @bespokeinvestnoted on X, “The 2-year Treasury yield has risen nearly a full percentage point up to 4.32% since the Iran War began.  It's predicting that fed funds (currently at 3.5-3.75%) is headed higher.” The 2-year note yield, which typically moves in step with Fed rate expectations, fell -3 basis points to 4.33%, its largest one-week basis point increase since May 11 at 16 basis points. The yield on benchmark U.S. 10-year notes fell -2.5 basis points to 4.679% today but posted its largest weekly increase since May 11 with a gain of 14 basis points.

 

Macro

Up/Down

Last

WTI Crude

-2.88

89.31

Brent

-3.91

96.78

Gold

20.60

4,070.80

EUR/USD

-0.0004

1.1372

JPY/USD

-0.03

163.82

10-Year Note

-0.025

4.679%

 

Sector News Breakdown

Retail, Consumer Staples & Restaurants:

  • Restaurant sector: CAKE was downgraded to Neutral at Mizuho citing its 28% share price increase (vs. the Russell 2000's 0.7% and the S&P500's-2.3%) since June 1 to a benefit from World Cup-related tourism that contributed to improving comp trends in June and into July.
  • Apparel/Footwear retail: DECK posted in-line Q2 sales of $1.02B and maintained its FY sales outlook of $5.86B-$5.91B while raising GY26 EPS view by a nickel vs. prior view to $7.35-$7.50 though noted Q2 gross margin is expected to be down due to tariffs and rising freight cost. GOOS was downgraded to Sell at Williams Trading saying there is a great risk that Canada Goose will cut or pull its FY27 guidance due to the potential additional 50% tariff on goods shipped to the U.S.

Autos, Leisure, Gaming & Lodging:

  • Casinos & Gaming: BYD Q2 Ebitda $350M was 3% above consensus expectations with overall brick-and-mortar EBITDAR coming in 1% ahead of expectations, flat YoY and in 1H26. Segment results were mixed, with continued headwinds in the Locals segment, despite beating consensus by 1%, and Downtown (6% miss), driven by weaker inbound visitation, renovation disruptions.
  • Lodging & Travel: B Riley said takeaways from STR expert call on online travel indicates U.S. saw healthy demand growth in Q2 while Europe softened. U.S. STR ADRs were +6.4%/+8.1% Y/Y for Q2/pacing Q3 with occupancy +2.1%/-0.8% Y/Y, respectively, while Europe STR ADRs (Euro denominated) were flat/+2% Y/Y for Q2/pacing Q3, with occupancy -1.1%/-4.1% Y/Y, respectively. ABNB led in STR share shifts across both markets, gaining +580 bps/+570 bps Y/Y in U.S./Europe share of bookings, respectively, with EXPE seeing STR booking share gains of +110 bps/+10 bps Y/Y in U.S./Europe and BKNG seeing STR bookings share gains of +50 bps/+260 bps Y/Y in U.S./Europe.

Energy, Industrials and Materials

  • In Oil Services: SLB beat Q2 Wall Street expectations for profit with EPS of $0.55 topping the $0.51 estimate on better revs $8.97B, lifting other service names (BKR, HAL), though the company flagged that Middle East first-half revenue declined on lower activity and conflict-related operational disruptions, with the timing of a full recovery remaining uncertain. Overall, the whole energy complex remains well bid this week as oil prices slip Friday, but up big on the week on Iran.  BP is in advanced talks to sell its solar business, Lightsource, to a consortium backed by Kuwait's sovereign wealth fund, the Financial Times reported. The total Baker Hughes oil and gas rig count, an early indicator of future output, fell by one to 587 in the week to July 24, the lowest since mid-July.
  • In Defense: PLTR shares bounced after the U.S. withdraws military intelligence contract bid after Palantir protest, Bloomberg reported. A U.S. government agency has withdrawn a solicitation to upgrade a military intelligence system used in lethal targeting after a protest filed by Palantir. BAH shares rallied on earnings results while forecasts FY adj. EPS to $6.00-$6.35 and revenue in the range of $11.2B-$11.70B vs analysts' est of EPS $6.29/$11.64B.
  • Paper & Packaging stocks outperformed after Truist noted earlier that PKG to raise containerboard prices; note shares of IP and SW were also notably higher on the day in Paper sector. Truist said the company announced a $140 per ton containerboard price increase to customers effective September 1st. In wallboard sector (CSL, OC, EXP), Truist noted Wallboard shipments, according to the major industry trade group, increased about 1% y/y during the second quarter, and increased about 2% when only looking at domestic destinations.

Banks, Brokers, Asset Managers:

  • Banking sector: HBAN was downgraded to Equal Weight at Morgan Stanley after posting its second NIM/NII miss and full-year guidance cut suggests competition is intensifying more than expected coming into the year/sees downside risk to HBAN's $1.90-1.93 EPS guide for 2027.
  • Mortgage sector remains pressured as names like RKT and ZG face mounting headwinds as the 30-year fixed mortgage rate climbed to 6.58%, its highest level in nearly a year, driven by rising oil prices and Middle East tensions stoking inflation fears.
  • Consumer Finance: AXP shares fall; Q2 revenue rose 10% y/y to $19.64B vs. est. $19.69B driven by higher card member spending while EPS of $4.53 topped the $4.41 estimate; raised full-year 2026 revenue growth guidance to 10% and maintains FY 2026 EPS guidance at $17.30 to $17.90.
  • FinTech: the WSJ reported Stripe is in talks to acquire OpenRouter, a startup that helps developers choose between artificial-intelligence models. The exact price being discussed couldn't be learned, but some of the people said the business could fetch about $10 billion in a sale – WSJ reported.
  • Financial Services: WSE shares fell after the U.S. Office of the Comptroller of the Currency denied Wise's application for a National Trust bank Charter as it was incompatible with Fed's new policies for payment system access; UPST receives conditional OCC approval to establish Upstart Bank, N.A., a nationally chartered bank built on AI-powered underwriting, following its March 2026 application.
  • Payments sector: FLYW was downgraded to Hold at Truist after the stock's strong performance (up +50% since it launched coverage last June) and as it expects revenue growth to decelerate, and PYPL was upgraded to Hold following the recent M&A news (it factors in a 75% probability that PayPal is purchased by Advent/Stripe at $62 per share in its price target). Truist is tactically more bullish on DLO and tactically more bearish on BILL.

Insurance & Services:

  • Insurance sector: HIG shares slipped after messy quarter as operating EPS of $3.42 topped ests $3.20 while underwriting was the primary source of weakness as the underlying loss ratio deteriorated 1.3pts y/y to 58.3%, with the pressure concentrated in Middle Market and National Accounts. KNSL reported Q2 EPS of $5.54 vs. est. $5.11E as beat was on better accident year margins and slightly more PYD/current accident year core loss ratio was strong at 57.0%, improving 1.1pts y/y; SIGI Q2 EPS of $1.95 above Street high estimate of $1.91 and est. $1.66 as Opco notes it was another quarter of no reserve charge in any segment or line/overall net written premium down -5.3% y/y, with Commercial down -5.5%, Personal down -8.1%, and E&S down -1.8%. PGR was upgraded to Equal Weight at Morgan Stanley saying valuation now fairer.

Biotech & Pharma:

  • LEGN downgraded to Neutral at UBS and cut tgt to $28 from $49 as believes JNJ's off-the-shelf Tecvayli & Talvey are setting new clinical benchmarks, plus Gilead's anito-cel will gain significant traction in Multiple Myeloma (MM); this shunts Carvykti's growth further.
  • MNKD said the FDA approved its single-use injection Furoscix ReadyFlow to treat fluid buildup or edema, in adults with heart failure or chronic kidney disease; the autoinjector delivers the drug furosemide under the skin, with IV-equivalent exposure, providing symptom relief in an hour or less
  • MRK reached voluntary licensing deals with seven companies to make generic versions of an experimental, once-a-month HIV prevention pill in 129 low- and middle-income countries.
  • NVO ‌said it is seeking a preliminary U.S. court injunction to immediately block obesity and diabetes drug advertisements by LLY.
  • OTLK said the FDA approved Lytenava for the treatment of neovascular age-related macular degeneration, commonly known as wet AMD.
  • SMMT announced up to $380M ATM equity sales program, with proceeds used to develop lead product candidate, ivonescimab, including clinical trials in non-small cell lung cancer (NSCLC), colorectal cancer; also posted Q2 net loss that narrowed to $215.7M, from $565.7M y/y.
  • SNY announced that, as part of an ongoing R&D review, amlitelimab will be discontinued in Atopic Dermatitis despite positive results from the ESTURY trial, as the data were not seen as sufficient to represent a meaningful improvement over the standard of care for patients with Atopic Dermatitis.
  • ZVRA shares slide after the European Medicines Agency's CHMP adopted a negative opinion on the co’s marketing application for arimoclomol, saying the treatment's efficacy had not been sufficiently demonstrated.

Healthcare Services & MedTech movers:

  • Hospital operators: THC shares jumped on results/guidance as Q2 adj EPS $6.12 vs. est. $4.26 and Q2 revs $5.63B vs. est. $5.44B; now sees FY26 adjusted EPS $20.30-$21.69 above consensus $17.85 and year revs $21.9B-$22.5B, vs. consensus $21.98B (better than comp CYH results the day prior). HCA posted Q2 revenue rose 8.7% y/y to $20.23B vs. est. $19.74B and EPS $7.62 beating $7.50 estimate with Q2 net income $1.70B, up 2.8% and adj. EBITDA $4.03B, up 4.6%; cuts FY26 EPS view to $28.70-$30.50 from $29.10-$31.50 and narrows FY26 revenue view to $77B-$79.5B from $76.5B-$80B.
  • Medical technology: EW shares rose after delivered an upside surprise on Q2 sales and EPS of 2% and 4% and was upgraded at Leerink saying co checks nearly all the boxes: 1) a positive earnings setup alongside continued commercial momentum and share gains in TAVR & TMTT, 2) an attractive catalyst path including the final TAVR NCD update, the high impact PROGRESS readout at TCT, and several upcoming TMTT launches, 3) multiple underappreciated tailwinds for TAVR
  • Healthcare Services: GEHC announced preliminary 2Q revenues of $5.295B vs. Street $5.264B estimate, or growth of 5.7% y/y (organic growth 3.5%) with adj. EPS performance ahead of expectation, and said CFO Jay Saccaro is to step down, remaining with the company thru Aug 14th

Internet, Media & Telecom

  • AI/Data Centers: Anthropic announced that Claude Opus 5 is now available. "It's a thoughtful and proactive model that comes close to the frontier intelligence of Claude Fable 5 at half the price," the company explained. "On coding and knowledge work evaluations like Frontier-Bench and GDPval-AA, Opus 5 is the new state-of-the-art, though it remains behind Mythos 5 on cybersecurity tasks. VZ secured a deal worth more than $1B to provide dark fiber connectivity for GOOGL data centers. A report in The Information said GOOGL’s Gemini 3 Flash outperformed Anthropic's Opus models on speed while costing a fraction as much, according to new data from NiCE. Citi placed an "upside 90-day catalyst watch" on DELL, citing great conviction in earnings momentum. DLR shares jumped as Q2 revenue rises 29% y/y to $1.9B, lifts 2026 revenue outlook to $6.85B-$6.95B, and core FFO outlook on strong customer demand; posted record bookings and rental rate increases on renewal leases supported revenue and backlog growth.
  • Telecom & Cable sector: VZ beat Q2 EPS ($1.30 vs. $1.27) and wireless service expectations, then raised its FY26 outlook as now sees adjusted EPS of $4.99-$5.04, up from a previous ceiling of $4.99; Q2 total operating revs $34.3B missed est. $35.16B, but Q2 postpaid phone net additions 184,000 topped estimates 103,900 with Q2 Broadband net additions 348,000. In cable, CHTR Q2 revs fell -1.7% y/y to $13.5B vs. est. $13.52B, as adj EBITDA declined 4.3% y/y -year to $5.4B as revenue fell and costs remained flat; Spectrum Internet customers declined by 172,000 in Q2, video customers decreased by 21,000 and fell by 107,000 y/y.

Hardware & Software movers:

  • Software sector: SAP reported mixed 2Q26 results with worse-than-expected non-IFRS EPS of EU159 vs. consensus EU1.75 and operating profit of EU2.74B vs. consensus EU2.89B citing the sequential deceleration of cloud and total revenue growth, an unusually low stock-based compensation expense in Q1, accelerated investments into R&D as well as the dilutive impact of the Reltio acquisition but revs of EU9.88B topped est. EU9.85B and cloud revenue of EU6.28B beat consensus EU6.26B. RNG reported a beat & raise 2Q, with revenue of $657M, up 5.9% Y/Y, and operating margins of 23.4%, up 90bps Y/Y and number of customers using at least one paid AI product has doubled Y/Y. CRM said the U.S. Department Of Veterans Affairs awarded them a $1.6B, 3-yr Agentic Enterprise License deal. ORCL signs 10-year software contract with Pentagon worth up to $7B/will supply on-premises software to the U.S. Department of Defense over 10 years in a contract worth up to $7B.

Semiconductors:

  • INTC posted its strongest revenue growth in more than fifteen years, with 2Q revenue of $16.1B (up 25% y/y), roughly $1.8B above the guidance midpoint, adj-GM of 41.8% (280bps above guide), and adj-EPS of $0.42 versus $0.20 guidance and $0.22 consensus. The quarter reflects a beat of ~12% on revenue, roughly double on EPS, and ~610bps on operating margin.
  • AMKR announced multi-year, $1.5B agreement with NVDA to expand advanced chip packaging and test capacity in the U.S.; partnership includes a prepayment from NVDA to support expansion of AMKR's U.S. advanced packaging operations, including capacity in Arizona.
  • MXL posted Q2 revenue of $168.8M (+23.1% q/q) came ahead of $165.0M sales estimate, with growth driven primarily by data center Optical interconnects within Infrastructure while Q3 revenue guided to a midpoint of $215.0M (+27.3% q/q; raised its CY26E Optical data center revenue guide to $210M-$230M (previously $150M-$170M).

Not offered or endorsed by Regal Securities

Street Recommendations

Friday, July 24, 2026

BARCLAYS

  • ACI Barclays lowered the firm's price target on Albertsons to $12 from $17 and keeps an Underweight rating on the shares post the Q1 report. The company's backdrop remains challenging, leading to a sales and profit outlook for fiscal 2026 coming in well below initial expectations, the analyst tells investors in a research note. The firm believes near-term improvement for Albertsons may be limited.
  • CMCSA Barclays analyst Kannan Venkateshwar lowered the firm's price target on Comcast to $26 from $28 and keeps an Equal Weight rating on the shares post the Q2 report. The company's turnaround plan appears to be on track but its second half performance will be key to understanding sustainability of the process, the analyst tells investors in a research note.
  • NSC Barclays analyst Brandon Oglenski raised the firm's price target on Norfolk Southern to $400 from $360 and keeps an Overweight rating on the shares post the Q2 report. The merger settlement agreement with CN is supportive of eventual Union Pacific-Norfolk Southern deal approval, the analyst tells investors in a research note. The firm says both Union Pacific and Norfolk are performing well as the fundamental backdrop for railroads improve.
  • TMUS Barclays analyst Kannan Venkateshwar lowered the firm's price target on T-Mobile to $215 from $230 and keeps an Overweight rating on the shares following the earnings report. T-Mobile's growth remains the strongest in the industry, but investor focus is on "second derivative shifts," the analyst tells investors in a research note. The firm says that if the changing competitive landscape involves industry partnerships that do not include T-Mobile, "it may be tough to get back narrative."
  • UNP Barclays raised the firm's price target on Union Pacific to $350 from $315 and keeps an Overweight rating on the shares. he merger settlement agreement with CN is supportive of eventual Union Pacific-Norfolk Southern deal approval, the analyst tells investors in a research note. The firm says both Union Pacific and Norfolk are performing well as the fundamental backdrop for railroads improve.
  • URI Barclays raised the firm's price target on United Rentals to $950 from $715 and keeps an Underweight rating on the shares following the Q2 report. The company has navigated the weak cycle better than peers, but the debate now shifts to its earnings leverage, the analyst tells investors in a research note. The firm says United Rentals' margin assumptions remain muted.

BMO CAPITAL

  • ACI BMO Capital downgraded Albertsons to Market Perform from Outperform with a price target of $12, down from $23. The firm says its thesis based on EBITDA stabilization for Albertsons "is proving elusive." With grocery competition set to increase from its key supermarket peer, Albertsons is not moving fast enough on cost reductions to fund better pricing, which drive concerns around its future profitability, the analyst tells investors in a research note. BMO cut its estimates and downgraded the shares post Albertsons' fiscal Q1 report.

BOFA

  • AMD BofA raised the firm's price target on AMD to $620 from $560 and keeps a Buy rating on the shares following the company's 2026 Advancing AI keynote and an investor Q&A with CEO Dr. Lisa Su. AMD has successfully transitioned from a merchant GPU vendor to a full-stack, rack-scale accelerator systems supplier and deepened an increasingly multi-generational roster of frontier-lab and hyperscale commitments, the analyst tells investors following the event.
  • THC BofA analyst Kevin Fischbeck raised the firm's price target on Tenet Healthcare to $265 from $230 and keeps a Buy rating on the shares. The quarter came in "well ahead of expectations" and Tenet raised the EBITDA guide by 6.4%, the analyst tells investors. Unlike peers, strong cost control and state directed payments helped drive the hospital outperformance, adds the analyst, who raised estimates following last night's report.
  • DECK BofA lowered the firm's price target on Deckers Outdoor to $105 from $115 and keeps a Neutral rating on the shares. Q1 "impresses," but Q2 guidance "disappoints," says the analyst, who adds that "all eyes" are on second half guidance that continues to include a ramp in sales growth and improving EBIT margins from more modest SG&A growth.

BTIG

  • CCSI BTIG raised the firm's price target on Consensus Cloud to $45 from $40 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 in Health Care IT and Digital Health. Since some hospital volumes, especially elective surgeries, are under pressure, due mainly to Exchange volume declines and increases in the uninsured, entities that are tied to Exchanges or that sell into hospitals may face some pressure, the analyst tells investors in a research note. The firm adds however that the e-faxing solutions improve revenue cycle operations and cash flow, so hospital CFOs may be more willing to buy from Consensus Cloud than other higher-cost items.
  • CYRX BTIG raised the firm's price target on Cryoport to $25 from $17 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 in Health Care IT and Digital Health. The Cell and Gene Therapy markets are coming back up, MVE has returned to healthy growth, and BioLogistics and BioStorage divisions have both returned to high-teens growth, the analyst tells investors in a research note.
  • HQY BTIG analyst David Larsen raised the firm's price target on HealthEquity to $115 from $110 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 in Health Care IT and Digital Health. While some of the hospitals are reporting that the consumer is more cautious due to the costs of oil, inflation, the war in the Middle East and other concerns, the overall labor markets are fairly healthy, the analyst tells investors in a research note.
  • LFST BTIG raised the firm's price target on LifeStance to $15 from $12 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 in Health Care IT and Digital Health. Assuming that trend for specialty medications and other services like mental health is high, the volume-based organizations should benefit, the analyst tells investors in a research note.
  • PGNY BTIG raised the firm's price target on Progyny to $40 from $30 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 in Health Care IT and Digital Health. While some of the hospitals are reporting that the consumer is more cautious due to the costs of oil, inflation, the war in the Middle East and other concerns, the overall labor markets are fairly healthy, the analyst tells investors in a research note.
  • PM BTIG raised the firm's price target on Philip Morris to $221 from $216 and keeps a Buy rating on the shares after its Q2 earnings beat. The firm is positive on the continued combustible strength and likely boosted sentiment around US pouches and broader heated, the former supported by outlined additional US investment.
  • MCD BTIG lowered the firm's price target on McDonald's to $350 from $370 and keeps a Buy rating on the shares. The firm has conducted its regular McDonald's franchise checks ahead of earnings to gauge recent sales trends, value traction, beverage results, and franchise sentiment, and the conversations pointed to muted results for the quarter, owing to general consumer malaise and difficult promotional comparisons versus last year, the analyst tells investors in a research note.
  • NVR BTIG lowered the firm's price target on NVR to $7,446 from $8,096 and keeps a Buy rating on the shares. The firm is citing the company's Q2 earnings miss as land deposit impairments, lower other income, and higher taxes drove the miss relative to its estimates. BTIG adds that home sales revenue was light as backlog conversion missed, though this was offset by better gross margins excluding charges, the analyst tells investors in a research note.

CANACCORD

  • MBLY Canaccord lowered the firm's price target on Mobileye to $12 from $17 and keeps a Buy rating on the shares.The firm said they still see a potential path forward for Mobileye in the evolving AV landscape, though the terrain is undeniably tougher. Mobileye operating its own robotaxi fleet looks like an attempt to spark momentum, and upcoming deployments, both with Volkswagen and independently; will be crucial test cases for the firm's thesis.
  • ROL Canaccord lowered the firm's price target on Rollins to $45 from $51 and keeps a Hold rating on the shares. The firm updated its model aft they reported Q2 results that were below expectations. Canaccord said given the large drop in the share price since the CFO transition was announced, we are warming to the story, but not there yet as business trends weaker and they're unsure whether it's a speed bump or a competitive issue.

CITI

  • DELL Citi analyst Asiya Merchant raised the firm's price target on Dell Technologies to $515 from $475 and keeps a Buy rating on the shares. Citi also opened an "upside 90-day catalyst watch" on Dell into the July quarter earnings report. Enterprise IT spending continues to ramp, creating a larger CPU market for the company, the analyst tells investors in a research note. Following AMD's analyst day and Intel's earnings report, Citi increased estimates for both Dell and HP Enterprise. It believes increased enterprise IT infrastructure spending continues to strengthen.
  • HPE Citi raised the firm's price target on HPE to $74 from $70 and keeps a Buy rating on the shares. Citi also opened an "upside 90-day catalyst watch" on HPE into the July quarter earnings report. Following AMD's analyst day and Intel's earnings report, the firm increased estimates for both Dell and HP Enterprise. It believes increased enterprise IT infrastructure spending continues to strengthen.
  • URI Citi analyst Kyle Menges raised the firm's price target on United Rentals to $1,330 from $1,270 and keeps a Buy rating on the shares. The firm updated the company's model post the Q2 report. It cites a more constructive rental revenue and margin outlook for the target boost.
  • PLTR Citi lowered the firm's price target on Palantir to $200 from $225 and keeps a Buy rating on the shares. The firm cites the stock's multiple compression for the target cut. However, it expects Palantir's U.S. commercial to rebound in Q2 after "unexpected deceleration" in Q1.
  • UNP Citi analyst Ariel Rosa raised the firm's price target on Union Pacific to $349 from $326 and keeps a Buy rating on the shares. The company reported a "solid beat-and-raise" quarter, the analyst tells investors in a research note. However, Citi sees limited room for further multiple expansion from current share levels.
  • LBRT Citi lowered the firm's price target on Liberty Energy to $28.50 from $32 and keeps a Buy rating on the shares following the Q2 report. The company increased capex to secure construction slots while pushing out power cash flow contribution expectations, the analyst tells investors in a research note. The firm says this is creating funding concerns.
  • AMBP Citi analyst Anthony Pettinari raised the firm's price target on Ardagh Metal Packaging to $6 from $5 and keeps a Buy rating on the shares. The company reported its eights straight EBITDA as Europe significantly outperformed in Q2, the analyst tells investors in a research note. Citi upped estimates following the earnings report.

GOLDMAN SACHS

  • BX Goldman Sachs analyst Alexander Blostein raised the firm's price target on Blackstone to $127 from $114 and keeps a Neutral rating on the shares. Blackstone's strong Q2 results reinforce a favorable outlook for alternative asset managers, supported by reaccelerating wealth channel inflows, resilient private credit demand, underappreciated AI exposure, continued fundraising strength, and improving prospects for asset monetization, the analyst tells investors in a research note.
  • CAR Goldman Sachs raised the firm's price target on Avis Budget to $95 from $85 and keeps a Sell rating on the shares. The firm raised its Q2 EBITDA estimate for Avis Budget, and expects results to keep the company on track for full-year guidance, with focus shifting to the sustainability of earnings in the second half of 2026 and beyond rather than a near-term guidance increase, the analyst tells investors in a research note.
  • TSCO Goldman Sachs analyst Kate McShane lowered the firm's price target on Tractor Supply to $38 from $43 and keeps a Buy rating on the shares. Tractor Supply shares rose despite a weak Q2 print, guidance cuts, and the withdrawal of long-term targets, as investors appeared encouraged by improving June/July trends and early pet category stabilization, the analyst says. However, a sustained recovery likely requires a return to low-single-digit sales growth and margin expansion, Goldman adds.
  • AAL Goldman Sachs analyst Catherine O'Brien lowered the firm's price target on American Airlines to $13 from $15 and keeps a Sell rating on the shares. American Airlines posted a better-than-expected Q2, but shares declined as higher fuel costs, aggressive capacity growth, and greater earnings sensitivity to oil prices weighed on the Q3 and FY26 outlook, the analyst tells investors in a research note.
  • RHI Goldman Sachs raised the firm's price target on Robert Half to $29 from $26 and keeps a Sell rating on the shares. Robert Half delivered mixed 2Q results as Talent Solutions recovery gained momentum, but worsening Protiviti weakness, macro uncertainty, and AI-related staffing risks pressured the earnings outlook, the analyst tells investors in a research note.

GUGGENHEIM

  • FUN Guggenheim lowered the firm's price target on Six Flags to $28 from $33 and keeps a Buy rating on the shares. The firm is updating its model to account for softer overall Q2 trends, the analyst tells investors. Progress is being made this year, but the firm believes the path to delever and fully turn the portfolio around "remains a multi-year effort," the analyst added.
  • TSCO Guggenheim lowered the firm's price target on Tractor Supply to $40 from $50 and keeps a Buy rating on the shares. Q2 operating results broadly missed the firm's expectations, but the firm sees a path to 2027 EPS growth, driven by an anticipated return of positive comp growth, the analyst tells investors.
  • SMMT Guggenheim analyst Brad Canino lowered the firm's price target on Summit Therapeutics to $38 from $40 and keeps a Buy rating on the shares. Management still expect to conduct the HARMONi-3 first-line squamous NSCLC final PFS analysis and take an early look at OS that should have high-teens months of follow-up that allows for a meaningful interpretation later in the second half of this year, but "the public topline disclosure after data cleaning could spill into early 2027," the analyst tells investors in a post-Q2 recap.

HSBC

  • INFY HSBC analyst Yogesh Aggarwal last night downgraded Infosys to Hold from Buy with a price target of $11.47, down from $14.24. The company reported a miss in the quarter, leading to a cut in fiscal 2027 revenue guidance, the analyst tells investors in a research note. HSBC attributes the miss and guide-down to one client contract termination in the energy vertical, manufacturing client ramp-down, and overall pricing deflation and offshore shift. The outlook suggests Infosys may underperform most of its peers in 2027, contends HSBC.
  • SPCX HSBC initiated coverage of SpaceX with a Hold rating and $115 price target. The company has a leading position in the commercial space launch market and strong innovation track record, the analyst tells investors in a research note. However, HSBC is "prudent on pricing in" SpaceX's futuristic calls including space data centers, Terafab, and the lunar economy. Even with an "innovation premium" for the shares, HSBC sees 0.2% downside from current levels. The firm's "blue-sky scenario" implies a valuation of $293 per share.

JPMORGAN

  • ROL JPMorgan analyst Tomohiko Sano downgraded Rollins to Neutral from Overweight with a price target of $45, down from $70, following the investor day. While the company's long-term thesis remains intact, near-term projections have "become tougher as industry demand has turned unusually volatile," the analyst tells investors in a research note. The firm says this "complicates the balance between" sustained investment and near-term margin estimates. JPMorgan now sees a less attractive risk/reward for Rollins shares.
  • STTK JPMorgan analyst Brian Cheng initiated coverage of Shattuck Labs with an Overweight rating and $10 price target. Shattuck is a clinical-stage biotech developing an anti-DR3 antibody program within the "familiar" TL1A axis, the analyst tells investors in a research note. The firm says the company is pursuing a differentiated strategy to tackle the same axis by targeting the associated receptor. It believes Shattuck's SL-325 data last month are encouraging, providing early evidence of reduced immunogenicity that could translate to improved efficacy and safety relative to the earlier generations of TL1A agents.
  • DLR JPMorgan raised the firm's price target on Digital Realty to $235 from $230 and keeps an Overweight rating on the shares. The firm views the company's Q2 report as strong. Digital Realty's raised its guidance on strong releasing performance, the analyst tells investors in a research note.

KEYBANC

  • TMUS KeyBanc analyst Brandon Nispel lowered the firm's price target on T-Mobile to $250 from $260 and keeps an Overweight rating on the shares. The firm notes Q2 wasn't great for KPIs and the lack of KPI guide raise was disappointing. That said, KeyBanc still sees upside to shares based on healthy mid-single-digit Service revenue growth and accelerating high-single-digit EBITDA growth profile organically, upside levers to drive ARPA and account growth, and a strong balance sheet. The firm takes the pullback as an opportunity to add to positions as T-Mobile remains the share gainer in Wireless and Broadband and is trading at a discounted valuation spread vs. history and peers.
  • URI KeyBanc raised the firm's price target on United Rentals to $1,350 from $1,250 and keeps an Overweight rating on the shares. Following United Rentals' Q2 beat-and-raise, the firm is raising its 2026 and 2027 estimates. KeyBanc thinks United Rentals remains the best positioned rental company given its outsized scale and exposure to large secular mega-projects. While time utilization remains at historically high levels driven by supply tightness for new equipment, the firm thinks industry conditions could support stronger rental rates and fleet productivity into 2027. Combined with its strong balance sheet optionality, it sees potential upside from M&A or further share repurchases.

MIZUHO

  • CAKE Mizuho downgraded Cheesecake Factory to Neutral from Outperform with a price target of $85, up from $75. The firm cites valuation for the downgrade with the shares up 28% since June 1. Mizuho attributes the rally to a benefit from World Cup-related tourism that brought improving comp trends in June and into July. However, the analyst sees limited visibility into underlying trends beyond the near-term for Cheesecake. The firm views the stock's current 35% premium to Cheesecake's casual dining peers as appropriate.

MORGAN STANLEY

  • HBAN Morgan Stanley downgraded Huntington Bancshares to Equal Weight from Overweight with a price target of $19, down from $21, following the Q2 report. The bank indicated that its net interest income could come in below the prior up 39%-43% guidance due to pressure on deposit pricing, the analyst tells investors in a research note. The firm believes intensifying competition will weigh on Huntington's loan and deposit pricing and net interest margin.
  • PGR Morgan Stanley analyst Bob Huang upgraded Progressive to Equal Weight from Underweight with a price target of $210, up from $190. The firm cites valuation for the upgrade. Progressive's current multiple is on the lower end of its historical valuation, the analyst tells investors in a research note. Morgan Stanley adds that Progressive's underwriting has been better than expected relative to its personal auto peers. The firm sees a fair valuation at current share levels.
  • PAG Morgan Stanley downgraded Penske Automotive to Equal Weight from Overweight with a price target of $210, up from $190. The firm cites valuation for the downgrade with the shares up 34% in the last three months. The takeover offer of $210 per share "likely introduces a near-term trading floor for the stock, limiting downside risk as the deal is reviewed by the special committee," the analyst tells investors in a research note. Morgan Stanley says thesis on the stock has played out.
  • INTC Morgan Stanley analyst Joseph Moore raised the firm's price target on Intel to $84 from $75 and keeps an Equal Weight rating on the shares. Intel reported stronger-than-expected upside and pointed to a higher level of spending tied to significant enthusiasm for long-term foundry prospects, the analyst tells investors in a post-earnings note. The firm adds that it is bullish on the CPU server market, though "less than some," "mixed at best" on Intel's server share prospects, and has "low conviction" in the company's foundry prospects.
  • LMT Morgan Stanley raised the firm's price target on Lockheed Martin to $690 from $653 and keeps an Equal Weight rating on the shares following what the firm calls "a growth-fueled beat-and-raise" in Q2. The embrace of faster, cheaper solutions is "promising" and a missiles ramp is also "encouraging," but framework agreements still must firm up into contracts, the analyst tells investors.
  • RTX Morgan Stanley analyst Kristine Liwag raised the firm's price target on RTX to $240 from $220 and keeps an Overweight rating on the shares. With strong demand across commercial aerospace and defense, a "strong beat-and-raise" in Q2 demonstrates that RTX's growth story and strong execution remain intact and reinforces a favorable setup into the second half and 2027, the analyst tells investors.

NEEDHAM

  • CROX Needham analyst Tom Nikic raised the firm's price target on Crocs to $150 from $132 and keeps a Buy rating on the shares ahead of its Q2 results next week. The stock has risen 55% year-to-date and the firm believes the move is justified as fundamentals are improving, particularly at Crocs North America, the analyst tells investors in a research note. Needham adds that its checks suggest strong demand trends in recent months, which could lead to solid GTC trends and a future restocking cycle at wholesale.
  • MXL Needham raised the firm's price target on MaxLinear to $100 from $60 and keeps a Buy rating on the shares. The company reported a Q2 beat with guidance that came in well ahead of estimates due to robust data center demand, the analyst tells investors in a research note. Needham adds that MaxLinear's data center portfolio continues to broaden, with new products expected to contribute meaningfully to growth in 2027 and 2028.
  • DECK Needham lowered the firm's price target on Deckers Outdoor to $125 from $138 and keeps a Buy rating on the shares. While the company reported a fine Q1, given the history of its big beats, investors are likely disappointed, the analyst tells investors in a research note. Needham adds, however, that DTC trends are solid, inventory/margin dynamics are favorable, and valuation is compelling.

PIPER SANDLER

  • COCO Piper Sandler analyst Michael Lavery raised the firm's price target on Vita Coco to $89 from $74 and keeps an Overweight rating on the shares. The firm notes the company reported a nice Q2 EBITDA beat, driven by lower year-over-year ocean freight costs, and higher pricing. It also reported Q2 sales above the Street, but its sales guidance range was somewhat conservative, ex-Copra, which is likely weighing on the stock, Piper adds.
  • ROL Piper Sandler lowered the firm's price target on Rollins to $46 from $72 and keeps an Overweight rating on the shares. The firm cites lower estimates and a lower multiple assumption, given a more challenging near-term outlook and inconsistent results in the last three quarters. Q2 results were quite disappointing, driven by Resi weakness in May, Piper adds.
  • TSCO Piper Sandler lowered the firm's price target on Tractor Supply to $31 from $32 and keeps a Neutral rating on the shares following Q2 results. A miss and guide-down was expected, and the firm walked away more positive following the Q2 earnings call and conversation with the company. While trends are expected to remain sluggish in the second half of the year, Tractor Supply is taking action to invest in price and improve share in companion animal.
  • EW Piper Sandler raised the firm's price target on Edwards Lifesciences to $101 from $100 and keeps an Overweight rating on the shares. The firm notes the company reported strong Q2 results tonight, with beats across all revenue segments. Overall, Piper views the results as all-around positive, and it expects shares to trade well. The firm sees a favorable stock set-up looking forward with good momentum in the business and a catalyst rich second half of the year.
  • TSLA Piper Sandler analyst Alexander Potter lowered the firm's price target on Tesla to $450 from $500 and keeps an Overweight rating on the shares. Following the Q2 results and publication of the 10-Q, the firm is cutting its 2026/2027 EPS estimates to reflect lower margins. This is particularly true in the Energy segment, but also in the Automotive segment. Piper is also cutting its estimates for regulatory credits. However, these revisions are partially offset by higher revenue, due to market share gains in the car market. The firm is also boosting its contribution from full self-driving software, and increasing its margins in the Service segment.
  • RNG Piper Sandler analyst James Fish raised the firm's price target on RingCentral to $43 from $40 and keeps a Neutral rating on the shares. The firm notes RingCentral reported a slightly better quarter than expected, expanded and extended its NICE partnership, increased its dividend already, restructured the Avaya relationship, and raised annual guide by roughly the Q2 subscription upside flow-through.

ROSENBLATT

  • INTC Rosenblatt raised the firm's price target on Intel to $80 from $65 and keeps a Sell rating on the shares after "a solid beat-n-raise" report, noting that demand for AI compute is pushing Intel's capacity limits. Management is increasing 2026 capex to $20B from what the firm estimates was about $15B, notes the analyst, who adds that 2027 and 2028 capex growth is expected to continue.

STIFEL

  • DECK Stifel lowered the firm's price target on Deckers Outdoor to $133 from $144 and keeps a Buy rating on the shares. The firm views the brand portfolio favorably, with HOKA marketplace dynamics healthier than last year and UGG driving steady mid-single digit percentage growth, though the firm trimmed its 12-month target price to reflect lowered revenue estimates and a lower assigned multiple, the analyst tells investors.
  • INTC Stifel lowered the firm's price target on Intel to $110 from $120 and keeps a Hold rating on the shares. The quarter reflects a beat of about 12% on revenue, roughly double on EPS, and about 610 basis points on operating margin in what the firm calls "a large, demand-led beat." However, the firm's stance remains that the 2026 re-rating "has already priced a meaningful chunk of the early turnaround" and the most important 14A catalyst, a signed external foundry customer, has "not yet arrived," the analyst tells investors.
  • LBRT Stifel lowered the firm's price target on Liberty Energy to $36 from $37 and keeps a Buy rating on the shares. Shares slid 22% following slightly better-than-expected Q2 results, which the firm views as likely related to a few factors, including a sharp rise in 2026 capital spending, higher spending expectations to reach its 3GW target, slightly later initial power generation EBITDA contribution, and general weakness in hyperscalers. However, it believes the story is intact and views the drop in shares as a buying opportunity, the analyst tells investors.
  • POOL Stifel lowered the firm's price target on Pool Corp. to $189 from $235 and keeps a Hold rating on the shares. The firm, which believes Q2 results and commentary "put Bulls on the sidelines while bringing bear arguments to the forefront," reduced its FY26-FY28 estimates and calls underperformance in the shares "appropriate."
  • SMMT Stifel analyst Dara Azar lowered the firm's price target on Summit Therapeutics to $38 from $45 and keeps a Buy rating on the shares. The firm thinks "timing is the nuance here," noting that HARMONi-level maturity is not expected until 2027, while the second half guidance for both PFS and OS remains in place. However, the firm remains "open-minded," acknowledges the public unknowns and still has its "fundamental conviction intact," the analyst added.

TD COWEN

  • DLR TD Cowen upgraded Digital Realty to Buy from Hold with a price target of $222, up from $192. The firm sees potential for further large signings in late 2026 or early 2027 for Digital Realty amid "record demand strength." Continued data center price increases, coupled with changing designs, should drive "notably higher" renewal spreads in future years for the company, the analyst tells investors in a research note. As such, TD believes Digital Realty is positioned for strong multi-year growth that is likely to accelerate in 2028.
  • BX TD Cowen analyst Bill Katz raised the firm's price target on Blackstone to $145 from $133 and keeps a Buy rating on the shares. The firm said its post post 2Q update reinforces their building view that the sector is nearing a favorable inflection point and they see a more decisive upward pivot, presuming geopolitical risks fade.
  • OZK TD Cowen lowered the firm's price target on Bank OZK to $52 from $53 and keeps a Hold rating on the shares. The firm noted NII expectations were lowered, with NIM declining in 2H and avgerage earning asset growth reduced, while expense guide increased.
  • BFH TD Cowen analyst Moshe Orenbuch raised the firm's price target on Bread Financial to $114 from $103 and keeps a Hold rating on the shares. The company reported better than expected Q2 results where Loan growth was stronger and the company raised its guide for loan/revenue growth and lowered the credit guide.

TELSEY ADVISORY

  • ACI Telsey Advisory downgraded Albertsons to Market Perform from Outperform with a price target of $13, down from $22, following the "soft" fiscal Q1 earnings report. The company's transformation "remains a work-in-progress," the analyst tells investors in a research note. The firm believes Albertsons is taking positive steps to transform the business. However, difficult macro trends, inconsistent execution, and incremental investments keep the company's visibility "clouded," adds Telsey.

TRUIST

  • FLYW Truist downgraded Flywire to Hold from Buy with a price target of $17, down from $18. The firm believes revenue growth will decelerate throughout 2026, in-part due to the lapping of some large clients being onboarded late last year, while also worried about intensifying geopolitical risk, the analyst tells investors.
  • PYPL Truist analyst Matthew Coad upgraded PayPal to Hold from Sell with a price target of $57, up from $44. While the firm continues to believe that the PayPal turnaround story will be difficult, it says it is difficult to make a call on the stock while there is the potential for a Stripe/Advent takeout. The Stripe bid is "real" and there are potential synergies in a combination of the two companies, the analyst added.

UBS

  • LEGN UBS downgraded Legend Biotech to Neutral from Buy with a price target of $28, down from $49. The firm sees a smaller opportunity for Carvykti due to intensifying competition from Anito-cel, Tecvayli and Talvey. Carvykti's growth has been "lackluster," the analyst tells investors in a research note.
  • TENB UBS downgraded Tenable (TENB) to Neutral from Buy with a price target of $37, up from $32. Despite the recent pullback, the shares are still up 75% since the Mythos announcement, and still appear to be pricing in high-single to low-double digit growth, the analyst tells investors in a research note. UBS believes that level of growth would likely require significant upside to Q2 estimates or a strong second half guide for investors to remain confident. The firm's channel checks indicate that Qualys (QLYS) is stepping up competitively, and increasingly competing with a remediation-focused approach, "which could be a differentiator in the current environment." It views Tenable's risk/reward as balanced at current share levels.
  • RTX UBS analyst Gavin Parsons raised the firm's price target on RTX to $215 from $198 and keeps a Neutral rating on the shares. RTX delivered another strong quarter with broad-based EBIT beats, strong Raytheon growth, Pratt & Whitney improvement, and resilient Collins margins, though elevated valuation and potential aftermarket headwinds remain key watch items, the analyst tells investors in a research note.
  • AMD UBS raised the firm's price target on AMD to $730 from $700 and keeps a Buy rating on the shares. AMD's AI Day strengthened the long-term outlook, with expectations for significant server CPU growth, improved supply visibility, and expanded data center GPU opportunities supporting a potential path toward substantially higher EPS by 2028, the analyst tells investors in a research note.

WELLS FARGO

  • ROL Wells Fargo analyst Jason Haas downgraded Rollins to Underweight from Equal Weight with a price target of $32, down from $46. The company's Q2 organic revenue and earnings came in below Street expectations and its fiscal 2026 targets were cut, the analyst tells investors in a research note. Wells says Rollins has reported softer growth trends in its residential business over the past three quarters. It sees risk to Rollins' historic premium multiple due to increased uncertainty.
  • CLF Wells Fargo raised the firm's price target on Cleveland-Cliffs to $11 from $9 and keeps an Equal Weight rating on the shares. A return to positive free cash flow and favorable second half of the year outlook pointed to a stronger 2027 result, prompting better prospects for debt paydown, the firm says. Wells suspected shares could squeeze, but valuation looking full and still elevated leverage keeps the firm on the sidelines.
  • DECK Wells Fargo analyst Ike Boruchow lowered the firm's price target on Deckers Outdoor to $85 from $90 and keeps an Underweight rating on the shares. The firm believes Q1 print adds more fuel to Bear Case and likely keeps Bulls from engaging despite valuation and lack of negative revisions. Wells cites another quarter where it thinks there are more questions than answers around the direction of the story.
  • SLM Wells Fargo lowered the firm's price target on SLM to $28 from $30 and keeps an Overweight rating on the shares. The firm notes the stock was down in aftermarket on higher NCO related to the debt resolution-related strategy change and related EPS miss. Management's tone on credit was positive, and a new loan sale fund partner should be announced near-term, Wells adds.

WILLIAMS TRADING

  • GOOS Williams Trading downgraded Canada Goose to Sell from Hold with a price target of C$10, down from C$12. There is "a great risk" that Canada Goose will cut or pull its FY27 guidance due to the potential additional 50% tariff on goods shipped to the U.S., the analyst tells investors.

Rating abbreviations…

***OP = Outperform

***SP = Sector Perform

***UP = Underperform

***OW = Overweight

***EW = Equal-weight

***UW = Underweight

 

 

 

***Report powered by thefly.com***

What’s on Tap Weekly Calendar

 

Monday July 27th

Economic Calendar: 

  • 8:30 AM ET                   Durable Goods Orders M/M for June
  • 8:30 AM ET                   Durable Goods Orders Ex Transportation M/M for June
  • 10:30 AM ET                 Dallas Fed Manufacturing Index for July
  • 1:00 PM ET US Treasury to sell $69B in 2-year notes
  • 1:00 PM ET US Treasury to sell $70B in 5-year notes

Earnings Calendar:

  • Earnings Before the Open: ARLP AZN BKR BMRC BOH HOPE NBN NE PERF
  • Earnings After the Close: AGYS AMKR APLD BLX BRO BRX CBK CBDNS CDP CINF CLS ESI FFIV FSUN KFRC KRC NBTN NTB NUE NVTS NWBI PFG RMBS RNGR SANM SSD SUI TFII UDR UHS WELL WHR

Tuesday July 28th

Economic Calendar: 

  • 7:45 AM ET ICSC Weekly Retail Sales
  • 8:30 AM ET                   Advance goods Trade Balance for June
  • 8:55 AM ET                   Johnson/Redbook Weekly Sales
  • 9:00 AM ET                   Monthly Home Price M/M for May
  • 9:00 AM ET                   CaseShiller 20-city index M/M for May
  • 10:00 AM ET                 Richmond Fed Manufacturing for July
  • 10:00 AM ET                 Consumer Confidence for July
  • 1:00 PM ET US Treasury to sell $44B in 7-year notes
  • 4:30 PM ET API Weekly Inventory Data

Earnings Calendar:

  • Earnings Before the Open: AB ABG ALKS AMT AWI AXTA BA CAC CARR CBU CMS CNC CTS CURB CVLT DINO DTE ECL FELE FMX GLW GSK HLT HRI HUBB INY INIO IQV ITRI ITW IVZ JBLU KO NAUT OSK PCAR PHG PII PNY PYPL RCL RGEN RITM RWT SHW SNDL SPGI SPWR TRU TXT TZOO UPS VNTG XIFR XPRO XYL
  • Earnings After the Close: AAT ACGL ACHC AKR APAM ASH AXS BE BXP CAKE CAR CHE CLW CNP CR CSGP CTO CZR ENPH EXE EXLS EXR F FCF FE GEF HIW HURN KLAC LOGI LSTR MANH MDLZ MEOH MIR NBR NEO NOV NXPI OI OMC ORN PDM PDS PPG QRVO QUAD RBBN RNST ROG RUSHA SBCF SLDE STAG STX SWKS TER THG TLRY TMRK TTAM UMBF UNM V VLTO VRNS WERN WM WPC ZWS

Other Key Events:

  • BTIG Biotech Virtual Conference, 7/28-7/29

Wednesday July 29th

Economic Calendar: 

  • 7:00 AM ET MBA Mortgage Applications Data
  • 10:30 AM ET                 Weekly DOE Inventory Data
  • 2:00 PM ET FOMC Policy Meeting concludes; no changes to rates expected

Earnings Calendar:

  • Earnings Before the Open: ADP AER AMRN ANIK AON APH ARCB ARCC AVTR AXGN BANC BAND BG BIIB BLCO BLKB BSX BTU CBRE CHEF CLH CLVT CSTM CTSH DBD EDU ETR EVR EXP FLEX FTRE FTV FVRR GD GEHC GNRC GRMN GTX HAYW HBM HUM IART IEX IONS JCI LEK LAD LFUS LII LMND LXP MAS MGPI MHO MNRO ODFL OGE OPCH PAG PB PG PRG PSN PUMP RDWR REYN SCL SHEN SITE SLGN SMG SOFI STRA SW SWK TEVA UBS UMC VFC VMC VRSK VRT WEC WING WNC WSO
  • Earnings After the Close: ADPT AEM AGI ALGN ALKT ALRS AM AR ARIS ARM ASTL AUR AWK BBNX BBT BELFA BHC BHE BN BOOM CBZ CHDN CHRW CLB CMG CMPT CMTG CNMD CNXN COUR CP CRK CSL CVI CVLG CVNA CWH EA EFOR EG EIG EPR EQIX ESRT ESS ETD FCPT FICO FLS FMC FORM FTAI FTNT GFL GKOS GRBK HLI HOOD HXL INVH KGC LHX LRCX LUNG LXU MAA MAX MC MDXG META MGM MOD MORN MSFT MTG MTH MX MYRG NEU NFG NGVT NSP NEW OHI ORLY PBI PCOR PEB PFSI PI PLXS PMT PPC PRCH PSA PTC QCOM QTWO REG RGR RM RSI SBUX SFM SIMO SONO ST TDOC TENB TK TNK TREE TTEK TYL UFPI UIS VET VICI VTR WAY WFG WHD WWD

Other Key Events:

  •  

Thursday July 30th

Economic Calendar: 

  • 8:30 AM ET                   Weekly Jobless Claims
  • 8:30 AM ET                   Continuing Claims
  • 8:30 AM ET                   Gross Domestic Product (GDP) for Q2
  • 8:30 AM ET                   Personal Consumption for Q2
  • 8:30 AM ET GDP Price Deflator for Q2
  • 8:30 AM ET PCE Price Index (headline) for Q2 M/M
  • 8:30 AM ET                   Core PCE Price Index for Q2 M/M
  • 8:30 AM ET                   Personal Income M/M for June
  • 8:30 AM ET                   Personal Spending M/M for June
  • 8:30 AM ET PCE Price Index headline M/M for June
  • 8:30 AM ET PCE Price Index headline Y/Y for June
  • 8:30 AM ET                   Core PCE Price Index (core) M/M for June
  • 8:30 AM ET                   Core PCE Price Index (core) Y/Y for June
  • 10:30 AM ET                 Weekly EIA Natural Gas Inventory Data

Earnings Calendar:

  • Earnings Before the Open: ABEV ADT AEP AG AGCO AGIO ALGM ALNY AMCX AMRX AOS APD APG AVY BAX BC BDC BDRBF BFLY BGC BI BLDR BMY BUD CCC CFR CHKP CI CMCO CNK CNX CRH CROX CRS CSW CWT DAR DFIN DSX DTM EEFT EME EPD EXC FCN FSS FTI GATX GIL GOOS GPI GVA H HGV HII HNI HSY ICE IDA IDCC IP JLL KBR KKR KRG LAUR LECO LH LKQ LNC LSPD LTH MA MCD MDGL MLM MO MYE NCLH NEOG NEXT OIS OMCL ONEW OWL PATK PBF PIPR PWR RACE REGN SAH SAIA SHEL SHOO SIRI SNY SO SOLS STLA STNG SXC TAL TE TRN TRP TRS TT TW UNIT VCEL VIRT VLO VRTS WBC WCC WTW XEL XHR XPO XRX YUM YUMC
  • Earnings After the Close: AAPL ACCO ADC AEE AJG AMH AMZN ASUR ATR AX AXTI BFAM BJRI BWIN CDNA CERS CNO COHU COIN COLM CPT CSTL CTVA CUBE CUZ DLB DRH DXC DXCM EGO EIX EMN ERIE ES EXPO FHI FLGT FND FORR FSLR GDDY GH GLPI GSIT HR HUN ILMN INGM IR IVR KWR LNT LOPE LPLA LYV MHK MMSI MPWR MSA MSTR MTD MTX MTZ NBIX NXT OCFC OLED OLN PBA PTCT RBLX RDDT RIVN RYAN SAFE SNDR SONY SPSC SPXC SYK TBKK TEM VCYT WU WY

Other Key Events:

  • China NBS Non-Manufacturing PMI for July
  • China NBS Manufacturing PMI for July

Friday July 31st

Economic Calendar: 

  • 8:30 AM ET                   Employment Cost index (ECI) for Q2
  • 9:45 AM ET                   Chicago PMI for July
  • 10:00 AM ET                 University of Michigan Sentiment, July-final
  • 10:00 AM ET                 University of Michigan 1-yr and 5-yr inflation expectations, July-final
  • 1:00 PM ET                    Baker Hughes Weekly rig count data

Earnings Calendar:

  • Earnings Before the Open: ABBV AN ARES BCPC BEN BEP BTSG CBOE CCJ CHD CL CVX D ENB EQX ETN FBIZ FET FRT FTS GTES LYIV LEA LIN LYB MGA MOGA MRNA NNOX NVT NWL POR PRLB PWP RBC SAN TROW VEON WT XOM
  • Earnings After the Close:

As a value-added service exclusive to Regal Securities account holders, The Hammerstone Report is available to read daily on the trading platform.

Hammerstone Inc. (the “Report”) provides information and data and does NOT provide any individual investment advice or money management assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer to buy or sell any securities. The Report is prepared for general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity.

Content is provided for educational and informational purposes only and Regal Securities cannot attest to its accuracy or completeness. No information provided has been endorsed by Regal Securities and does not constitute a recommendation by Regal Securities to buy or sell a particular investment. You are solely responsible for your own investment decisions and Regal Securities makes no investment recommendations and does not provide financial, tax, or legal advice. Regal Securities may provide links to internet sites maintained by third parties. Unless expressly stated otherwise, links in these reports are not sponsored by nor are they the responsibility of Regal Securities. Regal Securities has not verified the content, accuracy, or opinions expressed on any links in these reports and disclaims any warranty or liability for damages associated therewith.

Copyright 2006-2026 Regal Securities, Inc., Member FINRA/SIPC | Important Disclosures

Your privacy is important to us; see our Privacy Policy for details.

Regal Securities, 950 Milwaukee Ave., Ste. 102, Glenview, IL 60025
Website: www.regalsecurities.com | Toll-free: 1-877-488-6534
Representatives are available Monday through Friday from 8:00 a.m. to 5:00 p.m. EST.